From the GC Year in Review post the following one liner caught my attention:
"Development partners have also continued to assess TPM for inclusion in animal health applications with further studies planned early for the new year."
Although these development partners are still unaamed this comment suggests that animal health could be an off the radar hidden asset.
Kens
Ann: AVE begins Human Trial on CBD product, page-69
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.033K | 677.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 40284733 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39213269 | 30 |
View Market Depth
| Last trade - 11.43am 13/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |